Global Huperzine A Market , Forecast to 2026
- GEN3808022
- 113 Pages
- April 2020
- Healthcare
Key players profiled in this report are:
- Cisen Pharmaceutical Co., Ltd.
- Beijing Hwells Pharmaceutical Co., Ltd.
- Shanghai Fudan Forward Pharmaceutical Co., Ltd.
Other companies in the market include Debiopharm Group, XYMOGEN, Inc., Xel Pharmaceuticals, Inc., Hainan Lingkang Pharmaceutical Co., Ltd., Simcere Pharmaceutical Group, Henan Taloph Pharmaceutical Stock Co., Ningbo Liwah Pharmaceutical Co., Ltd., Ningbo Green-Health Pharma-ceutical Co., Ltd, Shenzhen Zhonglian Pharmaceutical Co., Ltd., Wanbang Pharmaceutical Group Co., Ltd., Zhejiang Judu Pharmaceutical Group Co.,Ltd., Zhejiang Zhenyuan Pharmaceutical Co., Ltd., Yaoyou Chongqing Pharmaceutical Co., Ltd., etc.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth rate of huperzine A in these regions, from 2020 to 2026, covering North America, Europe, Asia-Pacific and RoW. China reckoned as the most significant regional market and is anticipated to develop at a 6.8% CAGR from 2020 to 2026. Growing incidence of the Alzheimer’s and worldwide increase in the geriatric population are driving the China’s Alzheimer’s therapeutics market.
The base year of the study is 2019, and forecasts run up to 2026.
Research Objective
- To analyze and forecast the market size of global huperzine A market.
- To classify and forecast global huperzine A market based on region.
- To identify drivers and challenges for global huperzine A market.
- To examine competitive developments such as expansions, mergers & acquisitions, etc., in global huperzine A market.
- To identify and analyze the profile of leading players operating in global huperzine A market.
The report is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities. Key target audience are:
- Manufacturers of huperzine A
- Raw material suppliers
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to huperzine A
2. Objectives of The Study
3. Scope of the Report
3.1 Markets Covered
3.2 Years Considered for The Report
3.3 Currency
4. Market Research Methodology
5. Introduction
5.1 Overview
5.2 Natural Huperzine A and Synthetic Huperzine A
5.3 Value Chain
5.4 Mechanisms of Action
5.5 Product Form (Tablet, Capsule, Injection, etc.)
6. Product Pipeline
6.1 Wagelan/瓦格
6.2 Yinuo/忆诺
6.3 Shuangyiping/双益平
6.4 DEBIO 9902
6.5 MemorAll™
6.6 XEL 001HP
7. Rule, Regulation and Policy
7.1 Regulation and Policy in China
7.2 Regulation and Policy in Other Countries
8. Market Landscape
8.1 Market Size and Forecast
8.2 Market by Company
9. Alzheimer’s Disease
9.1 The Basics of Alzheimer’s Disease
9.2 Stages of Alzheimer's Disease
9.3 Therapies for Alzheimer's Disease
9.4 Huperzine A in the Treatment of Alzheimer's Disease
10. Huperzine A Market by Region
10.1 Huperzine A Market in North America
10.2 Huperzine A Market in Europe
10.3 Huperzine A Market in China
11. Drivers & Challenges
11.1 Market Growth Drivers
11.2 Market Challenges
11.3 Market Trends
12. Patents Analysis
12.1 Global Huperzine A Patents Analysis
12.2 China’s Huperzine A Patents Analysis
13. Key Vendor Analysis
13.1 Debiopharm Group
13.2 Cisen Pharmaceutical Co., Ltd.
13.3 Beijing Hwells Pharmaceutical Co., Ltd.
13.4 XYMOGEN, Inc.
13.5 Xel Pharmaceuticals, Inc.
13.6 Hainan Lingkang Pharmaceutical Co., Ltd.
13.7 Simcere Pharmaceutical Group
13.8 Henan Taloph Pharmaceutical Stock Co.
13.9 Ningbo Liwah Pharmaceutical Co., Ltd.
13.10 Ningbo Green-Health Pharma-ceutical Co., Ltd
13.11 Shanghai Fudan Forward Pharmaceutical Co., Ltd.
13.12 Shenzhen Zhonglian Pharmaceutical Co., Ltd.
13.13 Wanbang Pharmaceutical Group Co., Ltd.
13.14 Zhejiang Judu Pharmaceutical Group Co.,Ltd.
13.15 Zhejiang Zhenyuan Pharmaceutical Co., Ltd.
13.16 Yaoyou Chongqing Pharmaceutical Co., Ltd.
14. Attachment
DISCLAIMER
ABOUT GEN CONSULTING COMPANY
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
